Impact of left atrial diameter on all-cause mortality of patients with STEMI undergoing primary percutaneous coronary intervention

Kai Wang; Deli Zeng; Zijun Chen; Wei Yu

doi:10.15537/smj.2023.44.12.20230235

References

1.↵
1. Hudson M.
In suspected AMI, an extended algorithm increased sensitivity and decreased specificity for predicting 30-day MACE. Ann Intern Med 2020; 172: Jc11. Aitmokhtar O, Paganelli F, Benamara S, Azaza A, Bonello
OpenUrl
2.↵
1. Hamza O
L, Hamza O, et al. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis 2017; 110: 626-633.
OpenUrl
3.↵
1. Benjamin EJ,
2. Muntner P,
3. Alonso A,
4. Bittencourt MS,
5. Callaway CW,
6. Carson AP, et al.
Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation 2019; 139: e56-e528.
OpenUrl CrossRef PubMed
4.↵
1. Dobrin V,
2. Liubomir D,
3. Carlos C,
4. Kiril K,
5. Jivka S,
6. Ralica P, et al.
Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study. EuroIntervention 2018; 14: e530-e537.
OpenUrl PubMed
5.↵
1. Cho MS,
2. Park HS,
3. Cha MJ,
4. Lee SR,
5. Park JK,
6. Kim TH, et al.
Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation. Scientific reports 2021; 11: 23808.
OpenUrl
6.↵
1. Hamatani Y,
2. Ogawa H,
3. Takabayashi K,
4. Yamashita Y,
5. Takagi D,
6. Esato M, et al.
Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep 2016; 6: 31042.
OpenUrl PubMed
7.↵
1. Polovina MM,
2. Coats A,
3. Seferovic P.
Is left atrium the best kept secret of the heart? Left atrial dilatation and cardiovascular outcomes. Heart (British Cardiac Society) 2019; 105: 1848-1849.
OpenUrl FREE Full Text
8.↵
1. Yang L,
2. Zheng T,
3. Wu H,
4. Xin W,
5. Mou X,
6. Lin H, et al.
Predictive value of apelin-12 in patients with ST-elevation myocardial infarction with different renal function: a prospective observational study. BMJ open 2017; 7: e018595.
OpenUrl Abstract/FREE Full Text
9.↵
1. Bosch X,
2. Rovira M,
3. Sitges M,
4. Domènech A,
5. Ortiz-Pérez J,
6. de Caralt T, et al.
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). J Am Coll Cardiol 2013; 61: 2355-2362.
OpenUrl FREE Full Text
10.↵
1. Mosquera VX,
2. Bouzas-Mosquera A,
3. González-Barbeito M,
4. Bautista-Hernandez V,
5. Muñiz J,
6. Alvarez-García N, et al.
Indexed left atrial size predicts all-cause and cardiovascular mortality in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 2017; 153: 1275-84.e7.
OpenUrl PubMed
11.↵
1. Koh AS,
2. Murthy VL,
3. Sitek A,
4. Gayed P,
5. Bruyere J, Jr.,
6. Wu J, et al.
Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity. Eur J Nucl Med Mol Imaging 2015; 42: 1551-1561.
OpenUrl PubMed
12.↵
1. Chalasani N,
2. Younossi Z,
3. Lavine JE,
4. Charlton M,
5. Cusi K,
6. Rinella M, et al.
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67: 328-357.
OpenUrl CrossRef PubMed
13.↵
1. Canciello G,
2. de Simone G,
3. Izzo R,
4. Giamundo A,
5. Pacelli F,
6. Mancusi C, et al.
Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis View. J Am Soc Echocardiogr 2017; 30: 262-269.
OpenUrl PubMed
14.↵
1. Aquino GJ,
2. Decker JA,
3. Schoepf UJ,
4. Carson L,
5. Paladugu N,
6. Emrich AL, et al.
Utility of Functional and Volumetric Left Atrial Parameters Derived From Preprocedural Cardiac CTA in Predicting Mortality After Transcatheter Aortic Valve Replacement. AJR Am J Roentgenol 2022; 218: 444-452.
OpenUrl
15.
1. Li T,
2. Li G,
3. Guo X,
4. Li Z,
5. Yang J,
6. Sun Y.
Predictive value of echocardiographic left atrial size for incident stoke and stroke cause mortality: a population-based study. BMJ open 2021; 11: e043595.
OpenUrl
16.↵
1. O’Neill J,
2. Swoboda PP,
3. Plein S,
4. Tayebjee MH.
Left atrial size and function in a South Asian population and their potential influence on the risk of atrial fibrillation. Clin Cardiol 2018; 41: 1379-85.
OpenUrl
17.↵
1. Menichelli D,
2. Sciacqua A,
3. Cangemi R,
4. Andreozzi P,
5. Del Sole F,
6. Violi F, et al.
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study. Int J Clin Pract 2021; 75: e13771.
OpenUrl
18.↵
1. Wang HJ,
2. Li KL,
3. Li J,
4. Lin K,
5. Shi Y,
6. Wang H, et al.
Moderate chronic kidney disease and left atrial enlargement independently predict thromboembolic events and mortality in elderly patients with atrial fibrillation: a retrospective single-center study. J Int Med Res 2019; 47: 4312-4323.
OpenUrl
19.↵
1. Modin D,
2. Biering-Sørensen SR,
3. Møgelvang R,
4. Alhakak AS,
5. Jensen JS,
6. Biering-Sørensen T.
Prognostic value of left atrial strain in predicting cardiovascular morbidity and mortality in the general population. Eur Heart J Cardiovasc Imaging 2019; 20: 804-815.
OpenUrl
20.↵
1. Stolfo D,
2. Cinquetti M,
3. Merlo M,
4. Santangelo S,
5. Barbati G,
6. Alonge M, et al.
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis. Int J Cardiol 2016; 215: 340-345.
OpenUrl
21.↵
1. Bacaksiz A,
2. Vatankulu MA,
3. Kayrak M,
4. Telli HH,
5. Ayhan SS,
6. Sonmez O, et al.
Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction. Clinics (Sao Paulo, Brazil). 201368: 997-1003.
22.↵
1. Carluccio E,
2. Biagioli P,
3. Mengoni A,
4. Cerasa MF,
5. Lauciello R,
6. Zuchi C, et al.
Left Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection Fraction. Circ Cardiovasc Imaging 2018; 11: e007696.
OpenUrl
23.↵
1. Triposkiadis F,
2. Pieske B,
3. Butler J,
4. Parissis J,
5. Giamouzis G,
6. Skoularigis J, et al.
Global left atrial failure in heart failure. European journal of heart failure. 2016;18(11):1307-20.
OpenUrl
24.↵
1. Dzeshka MS,
2. Lip GY,
3. Snezhitskiy V,
4. Shantsila E.
Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications. J Am Coll Cardiol 2015; 66: 943-959.
OpenUrl FREE Full Text
25.↵
1. Thomas L,
2. Abhayaratna WP.
Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance. JACC Cardiovasc Imaging 2017; 10: 65-77.
OpenUrl Abstract/FREE Full Text
26.↵
1. Cao M,
2. Li T,
3. Li Z,
4. Gong F,
5. Chen Z.
A retrospective study on the relationship between fibrosis‑4 index and all‑cause mortality in patients with acute myocardial infarction. Exp Ther Med 2022; 24: 643.
OpenUrl
27.↵
1. Pavasini R,
2. Biscaglia S,
3. Barbato E,
4. Tebaldi M,
5. Dudek D,
6. Escaned J, et al.
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J 2020; 41: 4103-4110.
OpenUrl PubMed

In this issue

Download PDF

Email Article

Citation Tools

Bookmark this article

Cited By...

No citing articles found.

Google Scholar

More in this TOC Section

Show more Original Article

Keywords

[1] 1.↵
Hudson M.
In suspected AMI, an extended algorithm increased sensitivity and decreased specificity for predicting 30-day MACE. Ann Intern Med 2020; 172: Jc11. Aitmokhtar O, Paganelli F, Benamara S, Azaza A, Bonello
OpenUrl

[2] Hudson M.

[3] 2.↵
Hamza O
L, Hamza O, et al. Impact of platelet inhibition level on subsequent no-reflow in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis 2017; 110: 626-633.
OpenUrl

[4] Hamza O

[5] 3.↵
Benjamin EJ,
Muntner P,
Alonso A,
Bittencourt MS,
Callaway CW,
Carson AP, et al.
Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation 2019; 139: e56-e528.
OpenUrl CrossRef PubMed

[6] Benjamin EJ,

[7] Muntner P,

[8] Alonso A,

[9] Bittencourt MS,

[10] Callaway CW,

[11] Carson AP, et al.

[12] 4.↵
Dobrin V,
Liubomir D,
Carlos C,
Kiril K,
Jivka S,
Ralica P, et al.
Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study. EuroIntervention 2018; 14: e530-e537.
OpenUrl PubMed

[13] Dobrin V,

[14] Liubomir D,

[15] Carlos C,

[16] Kiril K,

[17] Jivka S,

[18] Ralica P, et al.

[19] 5.↵
Cho MS,
Park HS,
Cha MJ,
Lee SR,
Park JK,
Kim TH, et al.
Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation. Scientific reports 2021; 11: 23808.
OpenUrl

[20] Cho MS,

[21] Park HS,

[22] Cha MJ,

[23] Lee SR,

[24] Park JK,

[25] Kim TH, et al.

[26] 6.↵
Hamatani Y,
Ogawa H,
Takabayashi K,
Yamashita Y,
Takagi D,
Esato M, et al.
Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep 2016; 6: 31042.
OpenUrl PubMed

[27] Hamatani Y,

[28] Ogawa H,

[29] Takabayashi K,

[30] Yamashita Y,

[31] Takagi D,

[32] Esato M, et al.

[33] 7.↵
Polovina MM,
Coats A,
Seferovic P.
Is left atrium the best kept secret of the heart? Left atrial dilatation and cardiovascular outcomes. Heart (British Cardiac Society) 2019; 105: 1848-1849.
OpenUrl FREE Full Text

[34] Polovina MM,

[35] Coats A,

[36] Seferovic P.

[37] 8.↵
Yang L,
Zheng T,
Wu H,
Xin W,
Mou X,
Lin H, et al.
Predictive value of apelin-12 in patients with ST-elevation myocardial infarction with different renal function: a prospective observational study. BMJ open 2017; 7: e018595.
OpenUrl Abstract/FREE Full Text

[38] Yang L,

[39] Zheng T,

[40] Wu H,

[41] Xin W,

[42] Mou X,

[43] Lin H, et al.

[44] 9.↵
Bosch X,
Rovira M,
Sitges M,
Domènech A,
Ortiz-Pérez J,
de Caralt T, et al.
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies). J Am Coll Cardiol 2013; 61: 2355-2362.
OpenUrl FREE Full Text

[45] Bosch X,

[46] Rovira M,

[47] Sitges M,

[48] Domènech A,

[49] Ortiz-Pérez J,

[50] de Caralt T, et al.

[51] 10.↵
Mosquera VX,
Bouzas-Mosquera A,
González-Barbeito M,
Bautista-Hernandez V,
Muñiz J,
Alvarez-García N, et al.
Indexed left atrial size predicts all-cause and cardiovascular mortality in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 2017; 153: 1275-84.e7.
OpenUrl PubMed

[52] Mosquera VX,

[53] Bouzas-Mosquera A,

[54] González-Barbeito M,

[55] Bautista-Hernandez V,

[56] Muñiz J,

[57] Alvarez-García N, et al.

[58] 11.↵
Koh AS,
Murthy VL,
Sitek A,
Gayed P,
Bruyere J, Jr.,
Wu J, et al.
Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity. Eur J Nucl Med Mol Imaging 2015; 42: 1551-1561.
OpenUrl PubMed

[59] Koh AS,

[60] Murthy VL,

[61] Sitek A,

[62] Gayed P,

[63] Bruyere J, Jr.,

[64] Wu J, et al.

[65] 12.↵
Chalasani N,
Younossi Z,
Lavine JE,
Charlton M,
Cusi K,
Rinella M, et al.
The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67: 328-357.
OpenUrl CrossRef PubMed

[66] Chalasani N,

[67] Younossi Z,

[68] Lavine JE,

[69] Charlton M,

[70] Cusi K,

[71] Rinella M, et al.

[72] 13.↵
Canciello G,
de Simone G,
Izzo R,
Giamundo A,
Pacelli F,
Mancusi C, et al.
Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis View. J Am Soc Echocardiogr 2017; 30: 262-269.
OpenUrl PubMed

[73] Canciello G,

[74] de Simone G,

[75] Izzo R,

[76] Giamundo A,

[77] Pacelli F,

[78] Mancusi C, et al.

[79] 14.↵
Aquino GJ,
Decker JA,
Schoepf UJ,
Carson L,
Paladugu N,
Emrich AL, et al.
Utility of Functional and Volumetric Left Atrial Parameters Derived From Preprocedural Cardiac CTA in Predicting Mortality After Transcatheter Aortic Valve Replacement. AJR Am J Roentgenol 2022; 218: 444-452.
OpenUrl

[80] Aquino GJ,

[81] Decker JA,

[82] Schoepf UJ,

[83] Carson L,

[84] Paladugu N,

[85] Emrich AL, et al.

[86] 15.
Li T,
Li G,
Guo X,
Li Z,
Yang J,
Sun Y.
Predictive value of echocardiographic left atrial size for incident stoke and stroke cause mortality: a population-based study. BMJ open 2021; 11: e043595.
OpenUrl

[87] Li T,

[88] Li G,

[89] Guo X,

[90] Li Z,

[91] Yang J,

[92] Sun Y.

[93] 16.↵
O’Neill J,
Swoboda PP,
Plein S,
Tayebjee MH.
Left atrial size and function in a South Asian population and their potential influence on the risk of atrial fibrillation. Clin Cardiol 2018; 41: 1379-85.
OpenUrl

[94] O’Neill J,

[95] Swoboda PP,

[96] Plein S,

[97] Tayebjee MH.

[98] 17.↵
Menichelli D,
Sciacqua A,
Cangemi R,
Andreozzi P,
Del Sole F,
Violi F, et al.
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study. Int J Clin Pract 2021; 75: e13771.
OpenUrl

[99] Menichelli D,

[100] Sciacqua A,

[101] Cangemi R,

[102] Andreozzi P,

[103] Del Sole F,

[104] Violi F, et al.

[105] 18.↵
Wang HJ,
Li KL,
Li J,
Lin K,
Shi Y,
Wang H, et al.
Moderate chronic kidney disease and left atrial enlargement independently predict thromboembolic events and mortality in elderly patients with atrial fibrillation: a retrospective single-center study. J Int Med Res 2019; 47: 4312-4323.
OpenUrl

[106] Wang HJ,

[107] Li KL,

[108] Li J,

[109] Lin K,

[110] Shi Y,

[111] Wang H, et al.

[112] 19.↵
Modin D,
Biering-Sørensen SR,
Møgelvang R,
Alhakak AS,
Jensen JS,
Biering-Sørensen T.
Prognostic value of left atrial strain in predicting cardiovascular morbidity and mortality in the general population. Eur Heart J Cardiovasc Imaging 2019; 20: 804-815.
OpenUrl

[113] Modin D,

[114] Biering-Sørensen SR,

[115] Møgelvang R,

[116] Alhakak AS,

[117] Jensen JS,

[118] Biering-Sørensen T.

[119] 20.↵
Stolfo D,
Cinquetti M,
Merlo M,
Santangelo S,
Barbati G,
Alonge M, et al.
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis. Int J Cardiol 2016; 215: 340-345.
OpenUrl

[120] Stolfo D,

[121] Cinquetti M,

[122] Merlo M,

[123] Santangelo S,

[124] Barbati G,

[125] Alonge M, et al.

[126] 21.↵
Bacaksiz A,
Vatankulu MA,
Kayrak M,
Telli HH,
Ayhan SS,
Sonmez O, et al.
Assessment of the left atrial volume index and plasma NT-proANP level in patients with acute ST-elevation myocardial infarction. Clinics (Sao Paulo, Brazil). 201368: 997-1003.

[127] Bacaksiz A,

[128] Vatankulu MA,

[129] Kayrak M,

[130] Telli HH,

[131] Ayhan SS,

[132] Sonmez O, et al.

[133] 22.↵
Carluccio E,
Biagioli P,
Mengoni A,
Cerasa MF,
Lauciello R,
Zuchi C, et al.
Left Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection Fraction. Circ Cardiovasc Imaging 2018; 11: e007696.
OpenUrl

[134] Carluccio E,

[135] Biagioli P,

[136] Mengoni A,

[137] Cerasa MF,

[138] Lauciello R,

[139] Zuchi C, et al.

[140] 23.↵
Triposkiadis F,
Pieske B,
Butler J,
Parissis J,
Giamouzis G,
Skoularigis J, et al.
Global left atrial failure in heart failure. European journal of heart failure. 2016;18(11):1307-20.
OpenUrl

[141] Triposkiadis F,

[142] Pieske B,

[143] Butler J,

[144] Parissis J,

[145] Giamouzis G,

[146] Skoularigis J, et al.

[147] 24.↵
Dzeshka MS,
Lip GY,
Snezhitskiy V,
Shantsila E.
Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications. J Am Coll Cardiol 2015; 66: 943-959.
OpenUrl FREE Full Text

[148] Dzeshka MS,

[149] Lip GY,

[150] Snezhitskiy V,

[151] Shantsila E.

[152] 25.↵
Thomas L,
Abhayaratna WP.
Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance. JACC Cardiovasc Imaging 2017; 10: 65-77.
OpenUrl Abstract/FREE Full Text

[153] Thomas L,

[154] Abhayaratna WP.

[155] 26.↵
Cao M,
Li T,
Li Z,
Gong F,
Chen Z.
A retrospective study on the relationship between fibrosis‑4 index and all‑cause mortality in patients with acute myocardial infarction. Exp Ther Med 2022; 24: 643.
OpenUrl

[156] Cao M,

[157] Li T,

[158] Li Z,

[159] Gong F,

[160] Chen Z.

[161] 27.↵
Pavasini R,
Biscaglia S,
Barbato E,
Tebaldi M,
Dudek D,
Escaned J, et al.
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J 2020; 41: 4103-4110.
OpenUrl PubMed

[162] Pavasini R,

[163] Biscaglia S,

[164] Barbato E,

[165] Tebaldi M,

[166] Dudek D,

[167] Escaned J, et al.

Main menu

User menu

Search

Impact of left atrial diameter on all-cause mortality of patients with STEMI undergoing primary percutaneous coronary intervention

References

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS

Main menu

User menu

Search

Impact of left atrial diameter on all-cause mortality of patients with STEMI undergoing primary percutaneous coronary intervention

References

In this issue

Citation Manager Formats

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

CONTENT

JOURNAL

AUTHORS